| Affiliation: | 1. Multiple Sclerosis Centre of Catalonia (Cemcat), Department of Neurology‐Neuroimmunology, Vall d'Hebron University Hospital, Barcelona, Spain;2. Correspondence: For ECTRIMS: X. Montalban, Multiple Sclerosis Centre of Catalonia (Cemcat), Department of Neurology‐Neuroimmunology, Vall d'Hebron University Hospital, Pg. Vall d'Hebron, 119‐129, 08035 Barcelona, Spain (tel.: +34 93 2746202;3. fax: +34 93 2746084;4. e‐mail: );5. and;6. for EAN: R. Gold, Department of Neurology, Ruhr University, St Josef‐Hospital, Gudrunstr. 56, 44791 Bochum, Germany (tel.: +49‐234‐509244;7. fax: +49‐234‐5092414;8. e‐mail: ).;9. Department of Neurology, Ruhr University, St Josef‐Hospital, Bochum, Germany;10. Department of Brain Repair and Rehabilitation, Faculty of Brain Sciences, University College London Institute of Neurology, London, UK;11. Preventive Medicine and Epidemiology Department, Vall d'Hebron University Hospital, Barcelona, Spain;12. Department NEUROFARBA, Section Neurosciences, University of Florence, Florence, Italy;13. Multiple Sclerosis International Federation, London, UK;14. Department of Neurology, Toulouse University Hospital, Toulouse, France;15. Neurological Department, Institute of Experimental Neurology (INSPE), Scientific Institute Hospital San Raffaele, University Vita‐Salute San Raffaele, Milan, Italy;16. Departments of Neurology and Biomedicine, University Hospital Basel, Basel, Switzerland;17. Department of Neurology, Medical University of Graz, Graz, Austria;18. Department of Neurology, Medical Faculty, Multiple Sclerosis, Heinrich‐Heine‐University, Düsseldorf, Germany;19. Department of Neurology and Centre of Clinical Neuroscience, First Faculty of Medicine and General University Hospital, Charles University, Prague, Czech Republic;20. Department of Neurology, Klinikum Rechts der Isar, Technische Universit?t München, Munich, Germany;21. Munich Cluster for Systems Neurology (SyNergy), Munich, Germany;22. University Hospital Basel, Basel, Switzerland;23. INSERM UMR U1043 – CNRS U5282, Centre de Physiopathologie de Toulouse Purpan, Université de Toulouse, UPS, Toulouse, France;24. ICM‐GHU Pitié‐Salpêtrière, Sorbonne Universités UPMC Univ Paris 06, UMR_S 1127, Paris, France;25. Centre for Outcomes Research and Effectiveness (CORE), Research Department of Clinical, Educational and Health Psychology, University College London, London, UK;26. NMR Research Unit, Queen Square Multiple Sclerosis Centre, University College London (UCL) Institute of Neurology, London, UK;27. Neuroimmunology Unit, Centre for Molecular Medicine, L8:04, Karolinska University Hospital (Solna), Stockholm, Sweden;28. Department of Neurology, Medical University of Lodz, Lodz, Poland;29. Clinical Neuroimmunology Unit and MS Clinic, Department of Neurology, Cerrahpasa School of Medicine, Istanbul University, Istanbul, Turkey;30. Danish Multiple Sclerosis Centre, Department of Neurology, Copenhagen University Hospital Rigshospitalet, Copenhagen, Denmark;31. Biostatistics Unit, University of Genoa, Genoa, Italy;32. European Multiple Sclerosis Platform (EMSP), Schaerbeek/Brussels, Belgium;33. Department of Neurology, University of Münster, Münster, Germany;34. Department of Neurology, Focus Program Translational Neuroscience (FTN) and Immunology (FZI), Rhine‐Main Neuroscience Network (rmn2), University Medical Centre of the Johannes Gutenberg University Mainz, Mainz, Germany |
